Logo for Albireo Pharma Inc

Albireo Pharma Investor Relations Material

Latest events

Logo for Albireo Pharma Inc

Q3 2022

Albireo Pharma
Logo for Albireo Pharma

Q3 2022

8 Nov, 2022
Logo for Albireo Pharma

Study Result

11 Oct, 2022
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Albireo Pharma Inc

Access all reports
Albireo Pharma Inc. is a biopharmaceutical company specializing in the development and commercialization of treatments for rare liver diseases, particularly in pediatric and adult populations. The company’s focus is on conditions such as progressive familial intrahepatic cholestasis (PFIC), biliary atresia, and Alagille syndrome.